Description TB-500 + Bac Water 5mg/ml – Synthetic Peptide for Healing & Recovery
TB-500 + Bac Water is a synthetic peptide injection that replicates Thymosin Beta-4 (TB4), a naturally occurring protein involved in tissue repair and cellular regeneration. It promotes wound healing, recovery from muscle and tendon injuries, flexibility, and reduced inflammation. TB-500 regulates actin, enhances cellular migration, and stimulates angiogenesis, making it a powerful tool for athletes and recovery-focused individuals.
Available at www.cartelunited.eu.
Uses
-
Accelerates wound healing and tissue repair
-
Supports injury recovery in muscles, tendons, and joints
-
Improves flexibility and reduces stiffness
-
Reduces inflammation in chronic conditions like arthritis
-
Promotes blood vessel formation (angiogenesis)
-
Enhances cell migration and differentiation for tissue regeneration
Effects
-
Faster healing of acute and chronic wounds
-
Recovery from sports-related injuries
-
Reduced muscle and tendon stiffness
-
Improved joint mobility and flexibility
-
Anti-inflammatory effects for better tissue health
-
Regulation of actin protein for enhanced cell movement
Adverse Effects
-
Injection site reactions: pain, redness, irritation
-
Possible allergic reactions: rash, itching, swelling, difficulty breathing
-
Unknown long-term effects due to limited research
-
Potential interactions with medications or health conditions
-
Regulatory limitations depending on local laws
Dosage and Duration
-
Weekly dosage: 5–20 mg, divided into 2–3 injections
-
Maintenance dosage: approximately half or less of the initial dose, typically once per week
-
Proper sterile injection techniques and dosage adherence are essential
Combinations / Stacking
TB-500 can be combined with:
-
Prescription medications
-
Performance-enhancing drugs (PEDs)
-
Anti-inflammatory medications
-
Blood-thinning drugs
-
Supplements and nutraceuticals
-
Consideration for health conditions, recreational substances, and alcohol
Reviews 0
-
There are no reviews for this product.
-
No questions yet